- Home
- NAVN vs RXRX Comparison
NAVN vs RXRX Comparison
Compare NAVN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAVN | RXRX |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NAVN | RXRX |
|---|---|---|
| Price | $17.01 | $3.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $20.92 | $7.50 |
| AVG Volume (30 Days) | 2.7M | ★ 9.3M |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $26.56 | $12.11 |
| Revenue Next Year | $22.98 | $82.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $8.11 | $2.80 |
| 52 Week High | $20.27 | $7.18 |
Technical Indicators
Market Signals| Indicator | NAVN | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 77.57 | 43.25 |
| Support Level | $13.61 | $2.89 |
| Resistance Level | $18.15 | $3.99 |
| Average True Range (ATR) | 0.96 | 0.17 |
| MACD | 0.17 | -0.02 |
| Stochastic Oscillator | 97.83 | 9.29 |
Price Performance
Historical ComparisonAbout NAVN Navan Inc.
Navan Inc is an end-to-end, AI-powered software platform built to simplify the world-wide business T&E experience, benefiting users, customers, and suppliers. Its leveraged technology to reimagine business travel. The company deliver delightful, personalized experiences for users, efficiency and control for customers, and direct market access for suppliers-all powered by its proprietary AI framework, Navan Cognition. Geographically, the company operates in United States, United Kingdom and Other countries, of which United States derives maximum revenue.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.